Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

LEO Pharma

Status: Completed

Conditions: Psoriasis Vulgaris

Treatments: Drug: Daivobet® Gel

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT01320774

Treatment with Daivobet® Gel

Details and patient eligibility

About

The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.

Enrollment: 588 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with light to moderate psoriasis vulgaris of trunk and extremities and treatment with Daivobet® Gel was planned anyway

Exclusion criteria

• Previous therapy with Daivobet® Gel
• Systemic therapy of psoriasis vulgaris
• Contraindications of Daivobet® Gel in the German package insert